Using a smartphone app to help older adults with mild cognitive impairment take their blood pressure medications
Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment
This study is testing whether a smartphone app that sends medication reminders can help older adults with mild cognitive impairment take their blood pressure medications more regularly.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | University of Arizona Academic / other |
| Locations | 2 sites (Tucson, Arizona and 1 other locations) |
| Trial ID | NCT06307574 on ClinicalTrials.gov |
What this trial studies
The bpMedManage project aims to evaluate the effectiveness of a smartphone application designed to enhance medication adherence among older adults with mild cognitive impairment over a 16-week period. The study will involve 100 participants who will be randomly assigned to one of two groups: one receiving medication reminders and educational content through the app, and the other receiving only educational content. Both groups will undergo baseline assessments and medication adherence monitoring for four weeks. The goal is to determine if the app can significantly improve adherence to antihypertensive medications in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are community-dwelling older adults aged 60 and above who experience mild cognitive impairment and are capable of managing at least one prescribed antihypertensive medication.
Not a fit: Patients with a diagnosis of dementia or those living in assisted living or skilled nursing facilities may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could lead to improved management of hypertension in older adults, potentially reducing health complications associated with poor medication adherence.
How similar studies have performed: Other studies have shown promise in using digital health interventions to improve medication adherence, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 60+ 2. Community-dwelling older adults 3. Self-reported fluent in English 4. Adequate self-reported visual and hearing ability 5. Self-reported memory, thinking, or concentration challenges 6. Self-manage at least one prescribed antihypertensive medication 7. Have and use a smartphone 8. No self-reported history of major depression or other mental health diagnoses 9. No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease 10. TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26 11. Willing to participate in the study for at least 4 months Exclusion Criteria: 1. Diagnosis of dementia 2. Lives in assisted living facility or skilled nursing facility
Where this trial is running
Tucson, Arizona and 1 other locations
- University of Arizona — Tucson, Arizona, United States (Recruiting)
- University of Illinois, Urbana-Champaign — Champaign, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Kathleen Insel, PhD — University of Arizona
- Study coordinator: Kathleen Insel, PhD
- Email: insel@arizona.edu
- Phone: 520-626-6220
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.